BINEX Co., Ltd. (053030.KQ)
KRW 17490.0
(-3.95%)
KRW 17490.0
(-3.95%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 257.01 Billion KRW | -13.87% |
| 2022 | 298.4 Billion KRW | 9.51% |
| 2021 | 272.48 Billion KRW | 0.89% |
| 2020 | 270.09 Billion KRW | 33.19% |
| 2019 | 202.78 Billion KRW | 6.49% |
| 2018 | 190.42 Billion KRW | 13.5% |
| 2017 | 167.77 Billion KRW | -5.27% |
| 2016 | 177.1 Billion KRW | -2.04% |
| 2015 | 180.79 Billion KRW | 0.0% |
| 2013 | 122.26 Billion KRW | -14.97% |
| 2012 | 143.8 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 277.16 Billion KRW | 11.3% |
| 2024 Q1 | 249.03 Billion KRW | -3.1% |
| 2023 Q2 | 291.17 Billion KRW | -6.54% |
| 2023 Q3 | 279.95 Billion KRW | -3.85% |
| 2023 FY | 257.01 Billion KRW | -13.87% |
| 2023 Q4 | 257.01 Billion KRW | -8.2% |
| 2023 Q1 | 311.55 Billion KRW | 4.4% |
| 2022 Q1 | 276.52 Billion KRW | 1.48% |
| 2022 Q4 | 298.4 Billion KRW | 2.97% |
| 2022 Q3 | 289.81 Billion KRW | 2.72% |
| 2022 Q2 | 282.12 Billion KRW | 2.03% |
| 2022 FY | 298.4 Billion KRW | 9.51% |
| 2021 FY | 272.48 Billion KRW | 0.89% |
| 2021 Q3 | 253.61 Billion KRW | -1.99% |
| 2021 Q4 | 272.48 Billion KRW | 7.44% |
| 2021 Q1 | 269.49 Billion KRW | -0.22% |
| 2021 Q2 | 258.76 Billion KRW | -3.98% |
| 2020 Q4 | 270.09 Billion KRW | 23.77% |
| 2020 FY | 270.09 Billion KRW | 33.19% |
| 2020 Q3 | 218.22 Billion KRW | 5.48% |
| 2020 Q2 | 206.88 Billion KRW | 0.33% |
| 2020 Q1 | 206.2 Billion KRW | 1.69% |
| 2019 Q2 | 193.99 Billion KRW | 2.16% |
| 2019 FY | 202.78 Billion KRW | 6.49% |
| 2019 Q4 | 202.78 Billion KRW | 2.89% |
| 2019 Q3 | 197.07 Billion KRW | 1.59% |
| 2019 Q1 | 189.89 Billion KRW | -0.28% |
| 2018 FY | 190.42 Billion KRW | 13.5% |
| 2018 Q4 | 190.42 Billion KRW | 9.84% |
| 2018 Q3 | 173.35 Billion KRW | 1.54% |
| 2018 Q2 | 170.73 Billion KRW | -1.25% |
| 2018 Q1 | 172.89 Billion KRW | 3.05% |
| 2017 FY | 167.77 Billion KRW | -5.27% |
| 2017 Q1 | 179.58 Billion KRW | 1.4% |
| 2017 Q2 | 173.81 Billion KRW | -3.22% |
| 2017 Q4 | 167.77 Billion KRW | 0.0% |
| 2017 Q3 | - KRW | -100.0% |
| 2016 Q2 | 182.24 Billion KRW | -1.75% |
| 2016 FY | 177.1 Billion KRW | -2.04% |
| 2016 Q4 | 177.1 Billion KRW | -2.28% |
| 2016 Q3 | 181.24 Billion KRW | -0.55% |
| 2016 Q1 | 185.49 Billion KRW | 5.33% |
| 2015 Q4 | 176.11 Billion KRW | 0.0% |
| 2015 FY | 180.79 Billion KRW | 0.0% |
| 2014 Q3 | 135.47 Billion KRW | -0.65% |
| 2014 Q1 | 124.25 Billion KRW | 1.62% |
| 2014 Q2 | 136.36 Billion KRW | 9.75% |
| 2013 Q2 | 120.91 Billion KRW | -3.91% |
| 2013 FY | 122.26 Billion KRW | -14.97% |
| 2013 Q4 | 122.26 Billion KRW | -0.28% |
| 2013 Q3 | 122.61 Billion KRW | 1.41% |
| 2013 Q1 | 125.83 Billion KRW | -12.5% |
| 2012 Q4 | 143.8 Billion KRW | -1.19% |
| 2012 FY | 143.8 Billion KRW | 0.0% |
| 2012 Q3 | 145.52 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| HLB Co., Ltd. | 751.72 Billion KRW | 65.81% |
| iNtRON Biotechnology, Inc. | 98.61 Billion KRW | -160.622% |
| Bioneer Corporation | 315.48 Billion KRW | 18.535% |
| Anterogen.Co.,Ltd. | 149.43 Billion KRW | -71.993% |
| MEDIPOST Co., Ltd. | 449.39 Billion KRW | 42.809% |
| CrystalGenomics, Inc. | 243.11 Billion USD | -5.716% |
| Helixmith Co., Ltd | 227.27 Billion KRW | -13.082% |
| Chabiotech Co.,Ltd. | 1725.57 Billion KRW | 85.106% |
| Medy-Tox Inc. | 611.62 Billion KRW | 57.979% |
| Peptron, Inc. | 52.49 Billion KRW | -389.583% |
| Amicogen, Inc. | 467.09 Billion KRW | 44.977% |
| Genexine, Inc. | 376.58 Billion KRW | 31.752% |
| HLB Therapeutics Co.,Ltd. | 200.79 Billion KRW | -27.997% |
| LegoChem Biosciences, Inc. | 189.5 Billion KRW | -35.625% |
| ALTEOGEN Inc. | 256.09 Billion KRW | -0.356% |
| PharmaResearch Co., Ltd. | 535.28 Billion KRW | 51.986% |
| SillaJen, Inc. | 76.71 Billion KRW | -235.022% |
| JETEMA, Co., Ltd. | 252.14 Billion KRW | -1.929% |
| OliX Pharmaceuticals,Inc | 102.82 Billion KRW | -149.95% |
| Genomictree Inc. | 132.84 Billion KRW | -93.469% |
| MedPacto, Inc. | 80.47 Billion KRW | -219.37% |
| D&D Pharmatech | 79.2 Billion KRW | -224.494% |
| EASY BIO,Inc. | 172.04 Billion KRW | -49.389% |
| GI Innovation, Inc. | 81.34 Billion KRW | -215.971% |